2003

32nd Hemophilia Symposium

Hamburg 2001

ISBN: 978-3-540-43884-7 (Print) 978-3-642-18150-4 (Online)

Table of contents (50 chapters)

previous Page of 3
  1. Front Matter

    Pages II-XXIX

  2. Epidemiology

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-12

      HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2000/2001 Survey)

    3. No Access

      Book Chapter

      Pages 13-16

      Hemophilia 2001 — The Annual Survey of the Austrian Hemophilia Centers

    4. No Access

      Book Chapter

      Pages 17-18

      Epidemiology of Hemophilia in Switzerland: A first Insight in the Data Base achieved by the Medical Committee of the Swiss Hemophilia Association

    5. No Access

      Book Chapter

      Pages 19-22

      Overall Blood Supply Strategy with Regard to vCJD

  3. Genetic Diagnosis of Clotting Disorders

    1. Front Matter

      Pages 23-23

    2. Human Genome Project

      1. No Access

        Book Chapter

        Pages 25-31

        11 novel Mutations in the Factor VIII encoding Gene lead to severe or moderate Hemophilia A

      Register and Genetic Diagnosis

      1. No Access

        Book Chapter

        Pages 35-48

        Molecular Analysis of Hemophilia B: »Greifswald Registry FIX Deficiency (Hemophilia B)«

      2. No Access

        Book Chapter

        Pages 49-57

        Gly222Asp and Ser379Lys — Novel Factor X Gene Mutations in severe FX Deficiency — Greifswald Registry of Factor X congenital Deficiency

      Gene Therapy

      1. No Access

        Book Chapter

        Pages 61-71

        Hematopoietic Stem Cells as Targets for Gene Therapy of Hemophilia A

      2. No Access

        Book Chapter

        Pages 72-80

        Adenovirus-mediated regulatable Expression of human Factor IX in vitro and in vivo

  4. Hemophilia

    1. Front Matter

      Pages 81-81

    2. Orthopedics

      1. No Access

        Book Chapter

        Pages 83-86

        Experiences with MRI Examination of the Joints of hemophilic Children

      2. No Access

        Book Chapter

        Pages 87-91

        Rhenium-186 Hydroxyethylidenediphosphonate (186Re HEDP) — A novel Treatment for hemophilic Arthropathies?

      Monitoring of Substitution Therapy

      1. No Access

        Book Chapter

        Pages 95-100

        Monitoring of Anticoagulant Therapy with the endogenous Thrombin Potential

  5. Pediatric Hemostaseology

    1. Front Matter

      Pages 101-101

    2. No Access

      Book Chapter

      Pages 103-110

      First thromboembolic Onset in Children carrying either the heterozygeous Factor V G1691A Mutation or the Prothrombin G20210A Variant

    3. No Access

      Book Chapter

      Pages 111-114

      UFH Bolus Administration in Comparison to subcutaneous Low Molecular Weight Heparin in pediatric cardiac Catheterization

    4. No Access

      Book Chapter

      Pages 115-119

      Incidence of Inhibitor Development in consecutively recruited severe Hemophilia A and B Patients — a retrospective Single Centre Study

  6. Free Lectures

    1. Front Matter

      Pages 121-121

    2. No Access

      Book Chapter

      Pages 123-126

      Factor V Inhibitor and Anti-Phospholipid Antibodies after Treatment with Ciprofloxacin

    3. No Access

      Book Chapter

      Pages 127-130

      Isolated molecular Defects of von Willebrand Factor Binding to Collagen do not correlate with Bleeding Symptoms

    4. No Access

      Book Chapter

      Pages 131-137

      Effects of Tissue Factor Pathway Inhibitor and Antithrombin on Thrombin Generation in Tissue Factor-activated Cord Plasma

    5. No Access

      Book Chapter

      Pages 138-143

      Early and rapid Diagnosis of acute TTP by Measuring Activity of von-Willebrand Factor cleaving Metalloprotease (ADAMTS13): A Case Report

    6. No Access

      Book Chapter

      Pages 144-146

      Prions and the Safety of Plasma Proteins: Preventive Measures and Research Activities

previous Page of 3